New stem cells for medicine

The Care research institute will persue new approaches in regenerative medicine and drug development in Munich

June 15, 2016

Growing organs from skin cells, replacing animal experiments with new toxicity tests and stimulating human tissue to self-healing – all this could be made possible by stem cell research. In the "Center for Advanced Regenerative Engineering" (Care), scientists aim to develop technologies and therapies to use stem cells in medicine. The Bavarian State government supports this center, which is supposted to arise in Munich from January 2017, with fifteen million euro. In April, the scientists presented the Care institute for the first time to representatives of politics, ecomony and research.

A research object of the Care institute: nerve cells differentiated from human induced pluripotent stem cells.

Driving forces behind Care: Rüdiger Willems, Deputy Secretary General of the Max Planck Society, Hans Schöler, director at the Max Planck Institute for Molecular Biomedicine, Ilse Aigner, Bavarian State Minister of Economic Affairs and Media, Energy and Technology, Horst Domdey, Managing Director/CEO of BioM AG and Spokesman of "Bavarian Biotechnology Cluster" as well as Ulrich C. Gerth, designated managing director of Care at a convention, during which the institute was presented to representatives from politics, research and economy.

Go to Editor View